Literature DB >> 26967308

The DNA methylation profile of activated human natural killer cells.

John K Wiencke1, Rondi Butler2, George Hsuang1, Melissa Eliot2, Stephanie Kim2, Manuel A Sepulveda3, Derick Siegel3, E Andres Houseman4, Karl T Kelsey2,5.   

Abstract

Natural killer (NK) cells are now recognized to exhibit characteristics akin to cells of the adaptive immune system. The generation of adaptive memory is linked to epigenetic reprogramming including alterations in DNA methylation. The study herein found reproducible genome wide DNA methylation changes associated with human NK cell activation. Activation led predominately to CpG hypomethylation (81% of significant loci). Bioinformatics analysis confirmed that non-coding and gene-associated differentially methylated sites (DMS) are enriched for immune related functions (i.e., immune cell activation). Known DNA methylation-regulated immune loci were also identified in activated NK cells (e.g., TNFA, LTA, IL13, CSF2). Twenty-one loci were designated high priority and further investigated as potential markers of NK activation. BHLHE40 was identified as a viable candidate for which a droplet digital PCR assay for demethylation was developed. The assay revealed high demethylation in activated NK cells and low demethylation in naïve NK, T- and B-cells. We conclude the NK cell methylome is plastic with potential for remodeling. The differentially methylated region signature of activated NKs revealed similarities with T cell activation, but also provided unique biomarker candidates of NK activation, which could be useful in epigenome-wide association studies to interrogate the role of NK subtypes in global methylation changes associated with exposures and/or disease states.

Entities:  

Keywords:  DNA methylation; Differentially methylated regions; NK cells; NKp46; digital PCR; innate immunity

Mesh:

Substances:

Year:  2016        PMID: 26967308      PMCID: PMC4889279          DOI: 10.1080/15592294.2016.1163454

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  89 in total

1.  Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction.

Authors:  Zohreh Tatari-Calderone; Roshanak Tolouei Semnani; Thomas B Nutman; Jeffrey Schlom; Helen Sabzevari
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 2.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

Review 3.  NFAT proteins: key regulators of T-cell development and function.

Authors:  Fernando Macian
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

4.  Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development.

Authors:  Brendan Jones; Jianzhu Chen
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

Review 5.  Genome-wide association studies in type 1 diabetes.

Authors:  Struan F A Grant; Hakon Hakonarson
Journal:  Curr Diab Rep       Date:  2009-04       Impact factor: 4.810

6.  Epigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming.

Authors:  Kim L Harland; E Bridie Day; Simon H Apte; Brendan E Russ; Peter C Doherty; Stephen J Turner; Anne Kelso
Journal:  Nat Commun       Date:  2014-03-28       Impact factor: 14.919

7.  Interleukin-21 receptor signalling is important for innate immune protection against HSV-2 infections.

Authors:  Sine K Kratholm; Marie B Iversen; Line Reinert; Simon K Jensen; Marianne Hokland; Thomas Andersen; Andrew Rankin; Deborah Young; Sebastian Frische; Søren R Paludan; Christian K Holm
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  Differential expression of proteins in naïve and IL-2 stimulated primary human NK cells identified by global proteomic analysis.

Authors:  Weifeng Cao; Arvinder Kapur; Di Ma; Mildred Felder; Cameron O Scarlett; Manish S Patankar; Lingjun Li
Journal:  J Proteomics       Date:  2013-06-25       Impact factor: 4.044

9.  Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes.

Authors:  Yohko Kitagawa; Naganari Ohkura; Shimon Sakaguchi
Journal:  Front Immunol       Date:  2013-05-10       Impact factor: 7.561

10.  CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.

Authors:  Ariane Hammitzsch; Cynthia Tallant; Oleg Fedorov; Alison O'Mahony; Paul E Brennan; Duncan A Hay; Fernando O Martinez; M Hussein Al-Mossawi; Jelle de Wit; Matteo Vecellio; Christopher Wells; Paul Wordsworth; Susanne Müller; Stefan Knapp; Paul Bowness
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-10       Impact factor: 11.205

View more
  23 in total

1.  Enlarged leukocyte referent libraries can explain additional variance in blood-based epigenome-wide association studies.

Authors:  Stephanie Kim; Melissa Eliot; Devin C Koestler; Eugene A Houseman; James G Wetmur; John K Wiencke; Karl T Kelsey
Journal:  Epigenomics       Date:  2016-08-16       Impact factor: 4.778

Review 2.  Transcription Factor Bhlhe40 in Immunity and Autoimmunity.

Authors:  Melissa E Cook; Nicholas N Jarjour; Chih-Chung Lin; Brian T Edelson
Journal:  Trends Immunol       Date:  2020-10-07       Impact factor: 16.687

Review 3.  Immunomethylomics: A Novel Cancer Risk Prediction Tool.

Authors:  Karl T Kelsey; John K Wiencke
Journal:  Ann Am Thorac Soc       Date:  2018-04

4.  Leveraging cell-specific differentially methylated regions to identify leukocyte infiltration in adipose tissue.

Authors:  Su H Chu; Karl T Kelsey; Devin C Koestler; Eric B Loucks; Yen-Tsung Huang
Journal:  Genet Epidemiol       Date:  2019-08-21       Impact factor: 2.135

Review 5.  Immunological effects of hypomethylating agents.

Authors:  Katherine E Lindblad; Meghali Goswami; Christopher S Hourigan; Karolyn A Oetjen
Journal:  Expert Rev Hematol       Date:  2017-07-03       Impact factor: 2.929

Review 6.  Evolutionary and population (epi)genetics of immunity to infection.

Authors:  Luis B Barreiro; Lluis Quintana-Murci
Journal:  Hum Genet       Date:  2020-04-13       Impact factor: 4.132

Review 7.  The epigenetically-encoded memory of the innate immune system.

Authors:  Sarah Sun; Luis B Barreiro
Journal:  Curr Opin Immunol       Date:  2020-03-25       Impact factor: 7.486

8.  Distinct Epigenetic Effects of Tobacco Smoking in Whole Blood and among Leukocyte Subtypes.

Authors:  Dan Su; Xuting Wang; Michelle R Campbell; Devin K Porter; Gary S Pittman; Brian D Bennett; Ma Wan; Neal A Englert; Christopher L Crowl; Ryan N Gimple; Kelly N Adamski; Zhiqing Huang; Susan K Murphy; Douglas A Bell
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

9.  DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.

Authors:  Laura Baglietto; Erica Ponzi; Philip Haycock; Allison Hodge; Manuela Bianca Assumma; Chol-Hee Jung; Jessica Chung; Francesca Fasanelli; Florence Guida; Gianluca Campanella; Marc Chadeau-Hyam; Kjell Grankvist; Mikael Johansson; Ugo Ala; Paolo Provero; Ee Ming Wong; Jihoon Joo; Dallas R English; Nabila Kazmi; Eiliv Lund; Christian Faltus; Rudolf Kaaks; Angela Risch; Myrto Barrdahl; Torkjel M Sandanger; Melissa C Southey; Graham G Giles; Mattias Johansson; Paolo Vineis; Silvia Polidoro; Caroline L Relton; Gianluca Severi
Journal:  Int J Cancer       Date:  2016-10-11       Impact factor: 7.396

10.  Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis.

Authors:  Suresh Chava; Suresh Bugide; Yvonne J K Edwards; Romi Gupta
Journal:  Oncogenesis       Date:  2021-07-12       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.